We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
(+13%)
Cap. Flow
+$748M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$134M |
| 2 |
STMicroelectronics
STM
|
+$103M |
| 3 |
Meta Platforms (Facebook)
META
|
+$89.9M |
| 4 |
MetLife
MET
|
+$71.9M |
| 5 |
Gilead Sciences
GILD
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$161M |
| 2 |
Eli Lilly
LLY
|
+$153M |
| 3 |
MRSH
Marsh
MRSH
|
+$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$91.8M |
| 5 |
Electronic Arts
EA
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.43% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 8.07% |
| 4 | Energy | 6.4% |
| 5 | Financials | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDX
576
DELISTED
AvidXchange
AVDX
| $204K | ﹤0.01% |
+25,122
| New | +$237K |
|
577
Immunic
IMUX
$191M
| $196K | ﹤0.01% |
+11,865
| New | +$169K |
|
|
CASI
578
DELISTED
CASI Pharmaceuticals
CASI
| $188K | ﹤0.01% |
+30,532
| New | +$197K |
|
579
Rezolute
RZLT
$451M
| $181K | ﹤0.01% |
+37,343
| New | +$171K |
|
580
Arlo Technologies
ARLO
$1.73B
| $159K | ﹤0.01% |
+13,118
| New | +$174K |
|
581
Nu Holdings
NU
$69.9B
| $148K | ﹤0.01% |
+10,841
| New | +$146K |
|
582
Marqeta
MQ
$1.75B
| $127K | ﹤0.01% |
6,433
-1,062
| -14% | -$22.2K |
|
583
Karyopharm Therapeutics
KPTI
$43.3M
| $111K | ﹤0.01% |
8,941
| – | – |
|
|
CMRC
584
Commerce.com Inc Series 1
CMRC
$281M
| $108K | ﹤0.01% |
+18,529
| New | +$122K |
|
|
VISN
585
Vistance Networks Inc
VISN
$2.79B
| $88.4K | ﹤0.01% |
14,476
-95,631
| -87% | -$328K |
|
586
TTEC Holdings
TTEC
$128M
| $66.3K | ﹤0.01% |
+11,294
| New | +$61.6K |
|
587
AbCellera Biologics
ABCL
$1.81B
| – | – |
-12,163
| Closed | -$36K |
|
588
Adicet Bio
ACET
$85.6M
| – | – |
-30,381
| Closed | -$588K |
|
589
ADT
ADT
$5.63B
| – | – |
-70,432
| Closed | -$535K |
|
590
Adtran
ADTN
$641M
| – | – |
-24,509
| Closed | -$129K |
|
|
AGEN
591
Agenus
AGEN
$324M
| – | – |
-110,207
| Closed | -$1.85M |
|
592
Agios Pharmaceuticals
AGIO
$1.89B
| – | – |
-113,378
| Closed | -$4.89M |
|
593
AdaptHealth
AHCO
$884M
| – | – |
-782,913
| Closed | -$7.83M |
|
594
Akamai
AKAM
$17.8B
| – | – |
-10,223
| Closed | -$921K |
|
|
AL
595
DELISTED
Air Lease Corp
AL
| – | – |
-57,522
| Closed | -$2.73M |
|
596
Applied Materials
AMAT
$424B
| – | – |
-219,713
| Closed | -$51.9M |
|
597
Amcor
AMCR
$22.1B
| – | – |
-168,451
| Closed | -$8.24M |
|
|
AMED
598
DELISTED
Amedisys
AMED
| – | – |
-240,003
| Closed | -$22M |
|
599
Amylyx Pharmaceuticals
AMLX
$2.43B
| – | – |
-523,772
| Closed | -$995K |
|
600
Applovin
APP
$140B
| – | – |
-2,942
| Closed | -$245K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.
- Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
- Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
- Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
- Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
- Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
- Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
- Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.
Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.